{"id":"iopydol","rwe":[],"tags":[{"label":"iopydol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"V08AD02","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["iopydol"],"offLabel":[],"synonyms":["iopydol"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"iopydol","explanation":"Imagine your body's cells have locks on them, and Iopydol is a key that fits into one of those locks. When it binds to the lock, it can either turn the lock on or off, depending on the type of lock and the key's shape. This interaction can help regulate various bodily functions, but the exact details of how Iopydol works are not yet fully understood.","oneSentence":"Iopydol is a small molecule that works by interacting with a specific target in the body.","technicalDetail":"Iopydol's mechanism of action involves binding to a specific protein or receptor, which triggers a cascade of downstream effects that ultimately lead to its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4581","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=IOPYDOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:08:29.425743","biosimilars":[],"competitors":[{"drugName":"propyliodone","drugSlug":"propyliodone","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"iofendylate","drugSlug":"iofendylate","fdaApproval":"","relationship":"same-class"}],"genericName":"iopydol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"propyliodone","brandName":"propyliodone","genericName":"propyliodone","approvalYear":"","relationship":"same-class"},{"drugId":"iofendylate","brandName":"iofendylate","genericName":"iofendylate","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"003913","UNII":"T4661K682A","INN_ID":"1556","UMLSCUI":"C0771000","ChEMBL_ID":"CHEMBL2104393","KEGG_DRUG":"D04586","DRUGBANK_ID":"DB13389","PUBCHEM_CID":"21751"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"V08AD02","allCodes":["V08AD02"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"IOPYDOL","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iopydol is a small molecule drug of the iopydol class, but specific details about its development, ownership, and commercial status are not available. Its target and mechanism of action are also unknown. As a result, there is limited information available about its approved indications, half-life, bioavailability, and generic manufacturers. Iopydol's safety profile and potential side effects are also unclear. Further research is needed to fully understand this medication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}